Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Bjpsych Open|August 11, 2023
Personality functioning and self-disorders in individuals at ultra-high risk for psychosis, with first-episode psychosis and with borderline personality disorderMaria Gruber, Johanna Alexopoulos, Stephan Doering, et al.Psychopharmacology|January 20, 2007
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT studyNikolas Klein, Julia Sacher, Thomas Geiss-Granadia, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|August 12, 2025
Chronic pain in mental disorders: An umbrella review of the prevalence, risk factors, and treatments across 957,168 people with mental disorders and 16,606,910 controlsBrendon Stubbs, Ruimin Ma, Marco Solmi, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 18, 2011
Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association studyAlexandra Schosser, Monika Schloegelhofer, Karoline Fuchs, et al.The Australian and New Zealand Journal of Psychiatry|September 26, 2013
Duration of untreated psychosis in a high-income versus a low- and middle-income regionNilufar Mossaheb, Monika Schloegelhofer, Rainer M Kaufmann, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 23, 2013
Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trialG Paul Amminger, Andrew M Chanen, Susanne Ohmann, et al.The International Journal of Neuropsychopharmacology|February 21, 2006
Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligandJulia Sacher, Susanne Asenbaum, Nikolas Klein, et al.Biological Psychiatry|September 19, 2006
Reduced serotonin-1A receptor binding in social anxiety disorderRupert R Lanzenberger, Markus Mitterhauser, Christoph Spindelegger, et al.Schizophrenia Research|March 4, 2017
Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off valuesAkvile Bukenaite, Jan Stochl, Nilufar Mossaheb, et al.Early Intervention in Psychiatry|August 18, 2015
NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disordersConnie Markulev, Patrick D McGorry, Barnaby Nelson, et al.Pageof 8